Position in PFE
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$3,378,557
+$563,189 QoQ
Shares Held
120,319
+6.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Jackson Hole Capital Partners, LLC holds $25,097,540 across 8 Drug Manufacturers - General names. PFE ranks #4 (13.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
35,906 | $7,809,195 | |
| 2 | MRK |
Merck & Co., Inc.
|
62,790 | $7,553,009 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
33,305 | $4,641,717 | |
| 4 | PFE |
Pfizer Inc
This page
|
120,319 | $3,378,557 | |
| 5 | LLY |
ELI LILLY & Co
|
911 | $837,910 | |
| 6 | JNJ |
Johnson & Johnson
|
1,589 | $388,415 | |
| 7 | AMGN |
Amgen Inc
|
727 | $255,794 | |
| 8 | NVS |
Novartis AG
|
1,525 | $232,943 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,378,557 | 120,319 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $2,815,368 | 113,067 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $3,130,574 | 122,864 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $3,049,852 | 125,819 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $2,808,609 | 110,837 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $2,626,708 | 99,009 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $3,010,223 | 104,016 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $2,846,937 | 101,749 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,582,831 | 93,075 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,603,047 | 90,415 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $2,888,211 | 87,073 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $3,234,295 | 88,176 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,725,692 | 91,316 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,679,493 | 91,325 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $3,894,771 | 89,003 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $4,317,138 | 82,341 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $4,018,490 | 77,622 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $4,367,810 | 73,968 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $3,245,663 | 75,463 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $2,750,441 | 70,236 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $2,344,986 | 64,725 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $2,137,188 | 58,060 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $1,907,333 | 51,971 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $1,677,871 | 51,311 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,523,535 | 46,677 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||